RNA processing and human disease

Cellular and Molecular Life Sciences

Volumn 57, Issue 2, 2000, Pages 235-249

  Philips, A V ^a   Cooper, T A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alternative splicing; Pre mRNA; Spliceosome; U2AF

Indexed keywords

ANTIGEN; BINDING PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; RNA; RNA DERIVATIVE; TAU PROTEIN;

ALTERNATIVE RNA SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE ASSOCIATION; EXON; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MUTATION; MYOTONIC DYSTROPHY; NONHUMAN; PROTEIN DEFECT; REVIEW; RNA PROCESSING; SPINAL MUSCULAR ATROPHY;

EID: 0034020123     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000687     Document Type: Review

References (146)

1. 1 Matera A. G. (1998) Of coiled bodies, gems and salmon. J. Cell. Biochem. 70: 181-192
2. 2 Staley J. P. and Guthrie C. (1998) Mechanical devices of the spliceosome: motors, clocks, springs and things. Cell 92: 315-326
3. 3 Scott W. G. (1998) RNA catalysis. Curr. Opin. Struct. Biol. 8: 720-726
4. 4 Lafontaine D. L. and Tollervey D. (1998) Birth of the snoRNPs: the evolution of the modification-guide snoRNAs. Trends Biochem. Sci. 23: 383-388
5. 5 Walter P. and Johnson A. E. (1994) Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu. Rev. Cell. Biol. 10: 87-119
6. 6 Blackburn E. H. (1997) The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. Biochemistry 62: 1196-1201
7. 7 Askew D. S. and Xu F. (1999) New insights into the function of noncoding RNA and its potential role in disease pathogenesis. Histol. Histopathol. 14: 235-241
8. 8 Lanz R. B., McKenna N. J., Onate S. A., Albrecht U., Wong J., Tsai S. Y. et al. (1999) A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97: 17-27
9. 9 Colgan D. F. and Manley J. L. (1997) Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11: 2755-2766
10. 10 Gray N. K. and Wickens M. (1998) Control of translation initiation in animals. Annu. Rev. Cell. Dev. Biol. M: 399-458
11. 11 Decker C. J. and Parker R. (1995) Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr. Opin. Cell Biol. 7: 386-392
12. 12 Oleynikov Y. and Singer R. H. (1998) RNA localization: different zipcodes, same postman? Trends Cell. Biol. 8: 381-383
13. 13 L'Ecuyer T. J., Tompach P. C., Morris E. and Fulton A. B. (1995) Transdifferentiation of chicken embryonic cells into muscle cells by the 3′ untranslated region of muscle tropomyosin. Proc. Natl. Acad. Sci. USA 92: 7520-7524
14. 14 Rastinejad F. and Blau H. M. (1993) Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation. Cell 72: 903-917
15. 15 Berget S. M. (1995) Exon recognition in vertebrate splicing. J. Biol. Chem. 270: 2411-2414
16. 16 Black D. (1995) Finding splice sites within a wilderness of RNA. RNA 1: 763-771
17. 17 Chan R. C. and Black D. L. (1995) Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro. Mol. Cell. Biol. 15: 6377-6385
18. 18 Cooper T. A. (1999) Strategies for defining pre-mRNA cis elements that regulate cell specific splicing. In: Methods in Molecular Biology, vol. 118, pp. 391-403, Haynes S. R. (ed.), Humana Press, Totowa
19. 19 Zhang L., Ashiya M., Sherman T. G. and Grabowski P. J. (1996) Essential nucleotides direct neuron-specific splicing of gamma(2) pre-mRNA. RNA 2: 682-698
20. 20 Krawczak M., Reiss J. and Cooper D. N. (1992) The mutational spectrum of single base-pair substitutions in messenger RNA splice junctions of human genes - causes and consequences. Hum. Genet. 90: 41-54
21. 21 Nakai K. and Sakamoto H. (1994) Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 141: 171-177
22. 22 Rogan P. K., Faux B. M. and Schneider T. D. (1998) Information analysis of human splice site mutations. Hum. Mutat. 12: 153-171
23. 23 Moore M. J., Query C. C. and Sharp P. A. (1993) Splicing of precursors to mRNAs by the spliceosome. In: RNA World, pp. 305-358, Gesteland R. F. and Atkins R. J. (eds), Cold Spring Harbor Press Laboratory, Cold Spring Harbor, NY
24. 24 Tarn W. Y. and Steitz J. A. (1997) Pre-mRNA splicing: the discovery of a new spliceosome doubles the challenge. Trends Biochem. Sci. 22: 132-137
25. 25 Coulter L. R., Landree M. A. and Cooper T. A. (1997) Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell. Biol. 17: 2143-2150
26. 26 Cooper T. A. and Mattox W. (1997) The regulation of splice site selection and its role in human disease. Am. J. Hum. Genet. 61: 259-266
27. 27 D'Souza I., Poorkaj P., Hong M., Nochlin D., Lee V. M., Bird T. D. et al. (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA 96: 5598-5603
28. 28 Hong M., Zhukareva V., Vogelsberg-Ragaglia V., Wszolek Z., Reed L., Miller B. I. et al. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282: 1914-1917
29. 29 Si Z. H., Rauch D. and Stoltzfus C. M. (1998) The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Mol. Cell. Biol. 18: 5404-5413
30. 30 Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705
31. 31 Harper P. (1989) Myotonic Dystrophy, Saunders, Philadelphia
32. 32 Brook J. D., Mccurrach M. E., Harley H. G., Buckler A. J., Church D., Aburatani H. et al. (1992) Molecular basis of myotonic dystrophy - expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68: 799-808
33. 33 Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C. et al. (1992) Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355: 547-548
34. 34 Fu Y. H., Pizzuti A., Fenwick R. G., King J., Rajnarayan S., Dunne P. W. et al. (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256-1258
35. 35 Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G. et al. (1992) Myotonic dystrophy mutation an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255: 1253-1255
36. 36 Harper P. S. and Rudel R. (eds). (1993) Myotonic Dystrophy, McGraw-Hill, New York
37. 37 Fu Y. H., Friedman D. L., Richards S., Pearlman J. A., Gibbs R. A., Pizzuti A. et al. (1993) Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260: 235-238
38. 38 Krahe R., Ashizawa T., Abbruzzese C., Roeder E., Carango P., Giacanelli M. et al. (1995) Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 28: 1-14
39. 39 Maeda M., Taft C. S., Bush E. W., Holder E., Bailey W. M., Neville H. et al. (1995) Identification, tissue-specific expression and subcellular localization of the 80-and 71-kDa forms of myotonic dystrophy kinase protein. J. Biol. Chem. 270: 20246-20249
40. 40 Wang J., Pegoraro E., Menegazzo E., Gennarelli M., Hoop R. C., Angelini C. et al. (1995) Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 4: 599-606
41. 41 Berul C. I., Maguire C. T., Aronovitz M. J., Greenwood J., Miller C., Gehrmann J. et al. (1999) DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Invest. 103: R1 7
42. 42 Jansen G., Groenen P. J., Bachner D., Jap P. H., Coerwinkel M., Oerlemans F. et al. (1996) Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genet. 13: 316-324
43. 43 Reddy S., Smith D. B., Rich M. M., Leferovich J. M., Reilly P., Davis B. M. et al. (1996) Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet. 13: 325-335
44. 44 Otten A. D. and Tapscott S. J. (1995) Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. USA 92: 5465-5469
45. 45 Wang Y. H., Amirhaeri S., Kang S., Wells R. D. and Griffith J. D. (1994) Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 265: 669-671
46. 46 Wang Y. H. and Griffith J. (1995) Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elements. Genomics 25: 570-573
47. 47 Davis B. M., McCurrach M. E., Taneja K. L., Singer R. H. and Housman D. E. (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94: 7388-7393
48. 48 Hamshere M. G., Newman E. E., Alwazzan M., Athwal B. S. and Brook J. D. (1997) Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc. Natl. Acad. Sci. USA 94: 7394-7399
49. 49 Klesert T. R., Otten A. D., Bird T. D. and Tapscott S. J. (1997) Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genet. 16: 402-406
50. 50 Thornton C. A., Wymer J. P., Simmons Z., McClain C. and Moxley R. T. (1997) Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nature Genet. 16: 407-409
51. 51 Morrone A., Pegoraro E., Angelini C., Zammarchi E., Marconi G. and Hoffman E. P. (1997) RNA metabolism in myotonic dystrophy - patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J. Clin. Invest. 99: 1691-1698
52. 52 Timchenko L. T. (1999) Myotonic dystrophy: the role of RNA CUG triplet repeats. Am. J. Hum. Genet. 64: 360-364
53. 53 Timchenko L. T., Caskey C. T. and Swanson M. S. (1996) Myotonic dystrophy: discussion of molecular mechanism. Cold Spring Harbor Sym. Quant. Biol. 61: 607-614
54. 54 Taneja K. L., McCurrach M., Schalling M., Housman D. and Singer R. H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell. Biol. 128: 995-1002
55. 55 Timchenko L. T., Miller J. W., Timchenko N. A., Devore D. R., Datar K. V., Lin L. J. et al. (1996) Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24: 4407-4414
56. 56 Timchenko L. T., Timchenko N. A., Caskey C. T. and Roberts R. (1996) Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats - implications for myotonic dystrophy. Hum. Mol. Genet. 5: 115-121
57. 57 Roberts R., Timchenko N. A., Miller J. W., Reddy S., Caskey C. T., Swanson M. S. et al. (1997) Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. USA 94: 13221-13226
58. 58 Hwang D. M., Hwang W. S. and Liew C. C. (1994) Single pass sequencing of a unidirectional human fetal heart cDNA library to discover novel genes of the cardiovascular system. J. Molec. Cell. Card. 26: 1329-1333
59. 59 Lu X., Timchenko N. A. and Timchenko. L. T. (1999) Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8: 53-60
60. 60 Kim-Ha J., Kerr K. and Macdonald P. M. (1995) Translational regulation of oskar mRNA by bruno, an ovarian RNA-binding protein, is essential. Cell 81: 403-412
61. 61 Paillard L., Omilli F., Legagneux V., Bassez T., Maniey D. and Osborne H. B. (1998) EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. EMBO J. 17: 278-287
62. 62 Philips A. V., Timchenko L. T. and Cooper T. A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741
63. 63 Cooper T. A. (1998) Muscle-specific splicing of a heterologous exon mediated by a single muscle-specific splicing enhancer from the cardiac troponin T gene. Mol. Cell. Biol. 18: 4519-4525
64. 64 Ryan K. J. and Cooper T. A. (1996) Muscle-specific splicing enhancers regulate inclusion of the cardiac troponin T alternative exon in embryonic skeletal muscle. Mol. Cell. Biol. 16: 4014-4023
65. 65 Xiao S. H. and Manley J. L. (1997) Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 11: 334-344
66. 66 Sarkar P. S., Chang H. C., Boudi F. B. and Reddy S. (1998) CTG repeats show bimodal amplification in E. coli. Cell 95: 531-540
67. 67 Biros I. and Forrest S. (1999) Spinal muscular atrophy: untangling the knot? J. Med. Genet. 36: 1-8
68. 68 Burglen L., Lefebvre S., Clermont O., Burlet P., Viollet L., Cruaud C. et al. (1996) Structure and organization of the human survival motor neurone (SMN) gene. Genomics 32: 479-482
69. 69 Lefebvre S., Burglen L., Reboullet S., Clermont O., Burlet P., Viollet L. et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155-165
70. 70 Lorson C. L., Hahnen E., Androphy E. J. and Wirth B. (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 96: 6307-6311
71. 71 Monani U. R., Lorson C. L., Parsons D. W., Prior T. W., Androphy E. J., Burghes A. H. et al. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8: 1177-1183
72. 72 Bussaglia E., Clermont O., Tizzano E., Lefebvre S., Burglen L., Cruaud C. et al. (1995) A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nature Genet. 11: 335-337
73. 73 Chang J. G., Jong Y. J., Huang J. M., Wang W. S., Yang T. Y., Chang C. P. et al. (1995) Molecular basis of spinal muscular atrophy in Chinese. Am. J. Hum. Genet. 57: 1503-1505
74. 74 Lefebvre S., Burlet P., Liu Q., Bertrandy S., Clermont O., Munnich A. et al. (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nature Genet. 16: 265-269
75. 75 Melki J. (1997) Spinal muscular atrophy. Curr. Opin. Neurol. 10: 381-385
76. 76 Burghes A. H. (1997) When is a deletion not a deletion? When it is converted. Am. J. Hum. Genet. 61: 9-15
77. 77 Fischer U., Liu Q. and Dreyfuss G. (1997) The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90: 1023-1029
78. 78 Gavrilov D. K., Shi X., Das K., Gilliam T. C. and Wang C. H. (1998) Differential SMN2 expression associated with SMA severity. Nature Genet. 20: 230-231
79. 79 DiDonato C. J., Chen X. N., Noya D., Korenberg J. R., Nadeau J. H. and Simard L. R. (1997) Cloning, characterization and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. Genome Res. 7: 339-352
80. 80 Lorson C. L. and Androphy E. J. (1998) The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding. Hum. Mol. Genet. 7: 1269-1275
81. 81 Talbot K., Ponting C. P., Theodosiou A. M., Rodrigues N. R., Surtees R., Mountford R. et al. (1997) Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? Hum. Mol. Genet. 6: 497-500
82. 82 Lorson C. L., Strasswimmer J., Yao J. M., Baleja J. D., Hahnen E., Wirth B. et al. (1998) SMN oligomerization defect correlates with spinal muscular atrophy severity. Nature Genet. 19: 63-66
83. 83 Talbot K., Miguel-Aliaga I., Mohaghegh P., Ponting C. P. and Davies K. E. (1998) Characterization of a gene encoding survival motor neuron (SMN)-related protein, a constituent of the spliceosome complex. Hum. Mol. Genet. 7: 2149-2156
84. 84 Ponting C. P. (1997) Tudor domains in proteins that interact with RNA. Trends Biochem. Sci. 22: 51-52
85. 85 Neubauer G., King A., Rappsilber J., Calvio C., Watson M., Ajuh P. et al. (1998) Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex [see comments]. Nature Genet. 20: 46-50
86. 86 Coovert D. D., Le T. T., McAndrew P. E., Strasswimmer J., Crawford T. O., Mendell J. R. et al. (1997) The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6: 1205-1214
87. 87 Liu Q. and Dreyfuss G. (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15: 3555-3565
88. 88 Liu Q., Fischer U., Wang F. and Dreyfuss G. (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90: 1013-10121
89. 89 Pellizzoni L., Kataoka N., Charroux B. and Dreyfuss G. (1998) A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95: 615-624
90. 90 Fischer U. and Luhrmann R. (1990) An essential signaling role for the m3G cap in the transport of U1 snRNP to the nucleus. Science 249: 786-790
91. 91 Hamm J., Darzynkiewicz E., Tahara S. M. and Mattaj I. W. (1990) The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal. Cell 62: 569-577
92. 92 Kuncl R. W., Crawford T. O., Rothstein J. D. and Drachman D. B. (1992) Motor neuron disease. In: Diseases of the Nervous System, pp. 1179-1208, Asbury A. K., Mckhann G. M. and McDonald W. I. (eds), Saunders, Philadelphia
93. 93 Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62
94. 94 Fagg G. E. and Foster A. C. (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9: 701-719
95. 95 Gegelashvili G. and Schousboe A. (1998) Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res. Bull. 45: 233-238
96. 96 Furuta A., Martin L. J., Lin C. L., Dykes-Hoberg M. and Rothstein J. D. (1997) Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience 81: 1031-1042
97. 97 Rothstein J. D., Martin L., Levey A. I., Dykes-Hoberg M., Jin L., Wu D. et al. (1994) Localization of neuronal and glial glutamate transporters. Neuron 13: 713-725
98. 98 Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J. and Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38: 73-84
99. 99 Rothstein J. D., Martin L. J. and Kuncl R. W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326: 1464-1648
100. 100 Rothstein J. D., Dykes-Hoberg M., Pardo C. A., Bristol L. A., Jin L., Kuncl R. W. et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686
101. 101 Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K. et al. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699-1702
102. 102 Lin C. L., Bristol L. A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L. et al. (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20: 589-602
103. 103 Aoki M., Lin C. L., Rothstein J. D., Geller B. A., Hosler B. A., Munsat T. L. et al. (1998) Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol. 43: 645-653
104. 104 Meyer T., Munch C., Knappenberger B., Liebau S., Volkel H. and Ludolph A. C. (1998) Alternative splicing of the glutamate transporter EAAT2 (GLT-1). Neurosci. Lett. 241: 68-70
105. 105 Meyer T., Munch C., Volkel H., Booms P. and Ludolph A. C. (1998) The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia. J. Neurol. Neurosurg. Psychiatry 65: 594-596
106. 106 Munch C., Schwalenstocker B., Knappenberger B., Liebau S., Volkel H., Ludolph A. C. et al. (1998) 5′-Heterogeneity of the human excitatory amino acid transporter cDNA EAAT2 (GLT-1). Neuroreport 9: 1295-1297
107. 107 Haugeto O., Ullensvang K., Levy L. M., Chaudhry F. A., Honore T., Nielsen M. et al. (1996) Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271: 27715-27722
108. 108 Barrack E. R. (1996) Androgen receptor mutations in prostate cancer. Mt. Sinai J. Med. 63: 403-412
109. 109 Cooper D. L. and Dougherty G. J. (1995) To metastasize or not? Selection of CD44 splice sites. Nature Med. 1: 635-637
110. 110 Iwase H., Omoto Y., Iwata H., Hara Y., Ando Y. and Kobayashi S. (1998) Genetic and epigenetic alterations of the estrogen receptor gene and hormone independence in human breast cancer. Oncology 55: 11-16
111. 111 Pfeffer U. (1996) Estrogen receptor mRNA variants. Do they have a physiological role? Ann. N.Y. Acad. Sci. 784: 304-313
112. 112 Savagner P., Valles A. M., Jouanneau J., Yamada K. M. and Thiery J. P. (1994) Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol. Biol. Cell 5: 851-862
113. 113 Skuse G. R. and Cappione A. J. (1997) RNA processing and clinical variability in neurofibromatosis type I (NF1). Hum. Mol. Genet. 6: 1707-1712
114. 114 Rudzki Z. and Jothy S. (1997) CD44 and the adhesion of neoplastic cells. Mol. Pathol. 50: 57-71
115. 115 Yu Q. and Toole B. P. (1997) Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia. Dev. Dyn. 208: 1-10
116. 116 Jalkanen S., Bargatze R. F., de los Toyos J. and Butcher E. C. (1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol. 105: 983-990
117. 117 van Weering D. H., Baas P. D. and Bos J. L. (1993) A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl. 3: 100-106
118. 118 Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haußmann I. et al. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-25
119. 119 Guo Y., Ma J., Wang J., Che X., Narula J., Bigby M. et al. (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54: 1561-1565
120. 120 Horst E., Meijer C. J., Radaszkiewicz T., Ossekoppele G. J., Van Krieken J. H. and Pals S. T. (1990) Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/ 18) and ICAM-1 (CD54). Leukemia 4: 595-599
121. 121 Stamenkovic I., Amiot M., Pesando J. M. and Seed B. (1989) A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057-1062
122. 122 Zigmond S. H. (1989) Cell locomotion and chemotaxis. Curr. Opin. Cell Biol. 1: 80-86
123. 123 Sneath R. J. and Mangham D. C. (1998) The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol. 51: 191-200
124. 124 Zoller M. (1995) CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J. Mol. Med. 73: 425-438
125. 125 Takahashi K., Stamenkovic I., Cutler M., Saya H. and Tanabe K. K. (1995) CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 11: 2223-2232
126. 126 Tanabe K. K., Stamenkovic I., Cutler M. and Takahashi K. (1995) Restoration of CD44H expression in colon carcinomas reduces tumorigenicity. Ann. Surg. 222: 493-503
127. 127 Bartolazzi A., Peach R., Aruffo A. and Stamenkovic I. (1994) Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180: 53-66
128. 128 Stickeler E., Kittrell F., Medina D. and Berget S. M. (1999) Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574-3582
129. 129 Fu X. D. (1995) The superfamily of arginine/serine-rich splicing factors. RNA 1: 663-680
130. 130 Hertel K. J., Lynch K. W. and Maniatis T. (1997) Common themes in the function of transcription and splicing enhancers. Curr. Opin. Cell Biol. 9: 350-357
131. 131 Englert C. (1998) WT1 - more than a transcription factor? Trends Biochem. Sci. 23: 389-393
132. 132 Johnstone R. W., See R. H., Sells S. F., Wang J., Muthukkumar S., Englert C. et al. (1996) A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol. Cell. Biol. 16: 6945-6956
133. 133 Ye Y., Raychaudhuri B., Gurney A., Campbell C. E. and Williams B. R. (1996) Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J. 15: 5606-5615
134. 134 Larsson S. H., Charlieu J. P., Miyagawa K., Engelkamp D., Rassoulzadegan M., Ross A. et al. (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401
135. 135 Misteli T., Caceres J. F. and Spector D. L. (1997) The dynamics of a pre-mRNA splicing factor in living cells. Nature 387: 523-527
136. 136 Caricasole A., Duarte A., Larsson S. H., Hastie N. D., Little M., Holmes G. et al. (1996) RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc. Natl. Acad. Sci. USA 93: 7562-7566
137. 137 Tuerk C. and Gold L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510
138. 138 Bardeesy N. and Pelletier J. (1998) Overlapping RNA and DNA binding domains of the WT1 tumor suppressor gene product. Nucleic Acids Res. 26: 1784-1792
139. 139 Kennedy D., Ramsdale T., Mattick J. and Little M. (1996) An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modeling. Nature Genet. 12: 329-331
140. 140 Little M., Holmes G. and Walsh P. (1999) WT1: what has the last decade told us? Bioessays 21: 191-202
141. 141 Davies R. C., Calvio C., Bratt E., Larsson S. H., Lamond A. I. and Hastie N. D. (1998) WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev. 12: 3217-3225
142. 142 Armstrong J. F., Pritchard-Jones K., Bickmore W. A., Hastie N. D. and Bard J. B. (1993) The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Dev. 40: 85-97
143. 143 Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D., Gosden C. et al. (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197
144. 144 Barbaux S., Niaudet P., Gubler M. C., Grunfeld J. P., Jaubert F., Kuttenn F. et al. (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genet. 17: 467-470
145. 145 Klamt B., Koziell A., Poulat F., Wieacker P., Scambler P., Berta P. et al. (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 + / - KTS splice isoforms. Hum. Mol. Genet. 7: 709 714
146. 146 Wang J., Takagaki Y. and Manley J. L. (1996) Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev. 10: 2588-2599